We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Quality Systems (QSII) to Acquire Entrada for $34 Million
Read MoreHide Full Article
Irvine, CA-based Quality Systems, Inc. announced that it has entered into a deal to acquire Entrada, Inc. for $34 million.
Stock Performance
A glimpse of the company’s price trend reveals that the stock had an impressive run on the bourse over the past six months. Quality Systems added 24.74%, comparing favorably with the Zacks classified Medical Info Systems sub-industry’s loss of 1.93%. Also, the current level compares favorably with the S&P 500’s return of 9.66% over the same time frame.
Despite the bullish price trend, estimate revision for the stock has been dismal. The full year saw seven analysts move south over the last one month, with one movement in the opposite direction. As a result, the Zacks Consensus Estimate for the full year dropped 6% to 73 cents over the same time frame. Notably, the stock has Zacks Rank #3 (Hold).
Coming back to the news, the acquisition was to be made by Quality Systems’ wholly owned subsidiary NextGen Healthcare Information Systems unit. Based in Nashville, TN, Entrada is a leading provider of cloud-based solutions for healthcare. Entrada’s mobile app integrates with multiple clinical platforms and all major electronic health records.
Entrada clocked revenues of about $12 million in 2016 and a loss of about $2 million. The transaction is pending customary closing conditions.
Quality Systems is a developer and marketer of healthcare information systems. Going forward, we are upbeat about the performance of Quality System’s total software, hardware and related segments. However, the growth was partially offset by lower software license and hardware sales. Quality Systems continues to focus on growing its presence in the Revenue Cycle Management (RCM), population health and interoperability solution markets.
However, a sluggish global economy, increasing competition and a strict regulatory environment are the primary headwinds. Furthermore, although a recurring revenue stream is a positive for Quality Systems, it mostly comes from the lower margin Electronic data interchange (EDI) and RCM services.
Inogen has a long-term expected earnings growth rate of 17.50%. The stock registered an impressive one-year return of 64.2%.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a stellar one-year return of roughly 21.3%.
Sunshine Heart posted a positive earnings surprise of 58.24% in the last reported quarter. The stock has a stellar EPS growth record (last 3–5 years of actual earnings) of almost 22%.
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Quality Systems (QSII) to Acquire Entrada for $34 Million
Irvine, CA-based Quality Systems, Inc. announced that it has entered into a deal to acquire Entrada, Inc. for $34 million.
Stock Performance
A glimpse of the company’s price trend reveals that the stock had an impressive run on the bourse over the past six months. Quality Systems added 24.74%, comparing favorably with the Zacks classified Medical Info Systems sub-industry’s loss of 1.93%. Also, the current level compares favorably with the S&P 500’s return of 9.66% over the same time frame.
Despite the bullish price trend, estimate revision for the stock has been dismal. The full year saw seven analysts move south over the last one month, with one movement in the opposite direction. As a result, the Zacks Consensus Estimate for the full year dropped 6% to 73 cents over the same time frame. Notably, the stock has Zacks Rank #3 (Hold).
Coming back to the news, the acquisition was to be made by Quality Systems’ wholly owned subsidiary NextGen Healthcare Information Systems unit. Based in Nashville, TN, Entrada is a leading provider of cloud-based solutions for healthcare. Entrada’s mobile app integrates with multiple clinical platforms and all major electronic health records.
Entrada clocked revenues of about $12 million in 2016 and a loss of about $2 million. The transaction is pending customary closing conditions.
Quality Systems is a developer and marketer of healthcare information systems. Going forward, we are upbeat about the performance of Quality System’s total software, hardware and related segments. However, the growth was partially offset by lower software license and hardware sales. Quality Systems continues to focus on growing its presence in the Revenue Cycle Management (RCM), population health and interoperability solution markets.
However, a sluggish global economy, increasing competition and a strict regulatory environment are the primary headwinds. Furthermore, although a recurring revenue stream is a positive for Quality Systems, it mostly comes from the lower margin Electronic data interchange (EDI) and RCM services.
Key Picks
Better-ranked stocks in the broader medical sector include Inogen Inc. (INGN - Free Report) , Hologic, Inc. (HOLX - Free Report) and Sunshine Heart Inc . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Inogen has a long-term expected earnings growth rate of 17.50%. The stock registered an impressive one-year return of 64.2%.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a stellar one-year return of roughly 21.3%.
Sunshine Heart posted a positive earnings surprise of 58.24% in the last reported quarter. The stock has a stellar EPS growth record (last 3–5 years of actual earnings) of almost 22%.
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>